우리나라의 한약 부작용 규모 추정
Estimation of Adverse Events Scale relating Herbal Medicine in Korea
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives : The purpose of study was estimation of adverse events [AEs] scale relating herbal medicine in Korea using Korean Medicine Utilization and Herbal Medicine Consumption Survey (National statistics No. 117087). Methods : Using microdata of Korean Medicine Utilization and Herbal Medicine Consumption Survey 2017, the number of inpatients and outpatients who experienced AEs was calculated. The microdata included AEs of all treatment methods that have been performed by visiting Korean medical institutions for one year, so set up the data into three models; model A (in case all treatments were only herbal medicine for one year), model B (in case herbal medicines were a part of all treatment methods in 1 year), model C (in case herbal medicines were a part of treatment methods at least one time in 1 year). The proportion of patients who experienced AEs during the last 1 year was calculated and then, the number of AEs relating herbal medicine was estimated. Results : A total of 1,010 outpatients and 904 inpatients were included in Korean Medicine Utilization and Herbal Medicine Consumption Survey 2017. The number of patients who had experienced AEs in the past 1 year was 0 in the model A, 9 in the model B (5 for outpatients, 4 for inpatients), and 19 in the model C (10 for outpatients, 9 for inpatients). By consideration for the complex sample survey, estimating the number of AEs relating herbal medicine, the model A was 0, the model B was 36,457 patients (0 to 75,526 patients), and the model C was 84,830 patients (26,314 to 143,347 patients). Conclusion : From the results of this study, it was possible to estimate the scale of AEs relating herbal medicines in Korea, suggesting that it is necessary to understand the actual condition of AEs and establish its management system.
Abstract
Objectives : The purpose of study was estimation of adverse events [AEs] scale relating herbal medicine in Korea using Korean Medicine Utilization and Herbal Medicine Consumption Survey (National statistics No. 117087). Methods : Using microdata of Korean Medicine Utilization and Herbal Medicine Consumption Survey 2017, the number of inpatients and outpatients who experienced AEs was calculated. The microdata included AEs of all treatment methods that have been performed by visiting Korean medical institutions for one year, so set up the data into three models; model A (in case all treatments were only herbal medicine for one year), model B (in case herbal medicines were a part of all treatment methods in 1 year), model C (in case herbal medicines were a part of treatment methods at least one time in 1 year). The proportion of patients who experienced AEs during the last 1 year was calculated and then, the number of AEs relating herbal medicine was estimated. Results : A total of 1,010 outpatients and 904 inpatients were included in Korean Medicine Utilization and Herbal Medicine Consumption Survey 2017. The number of patients who had experienced AEs in the past 1 year was 0 in the model A, 9 in the model B (5 for outpatients, 4 for inpatients), and 19 in the model C (10 for outpatients, 9 for inpatients). By consideration for the complex sample survey, estimating the number of AEs relating herbal medicine, the model A was 0, the model B was 36,457 patients (0 to 75,526 patients), and the model C was 84,830 patients (26,314 to 143,347 patients). Conclusion : From the results of this study, it was possible to estimate the scale of AEs relating herbal medicines in Korea, suggesting that it is necessary to understand the actual condition of AEs and establish its management system.
참고문헌 (15)
- Korean Society for Pharmacoepidemiology and Risk Management, "Pharmacoepidemiology" (2012), SNU Press
- 최돈웅, "우리나라의 의약품 안전관리 현황", 대한의사협회지, 55(9), pp.827~834 (2012), 대한의사협회
- 식품의약품안전처, "2019 식품의약품통계연보 제21호", ~ (2019)
- "건강보험 빅데이터로“약물 부작용 줄이고, 국민안전 올리고!”"[URL]
- 최혁재, "의료기관내 한약부작용 보고현황과 활용방안", 2017년 대한약물역학위해관리학회 추계학술대회 발표자료 (2017)
- 보건복지부, "2017년 한방의료이용및 한약소비실태조사 마이크로데이터 이용지침서", ~ (2018)
- Lazarou J, "Incidence of adverse drug reactions in hospitalized patients; a meta-analysis of prospective studies", JAMA, 279(15), pp.1200~1205 (1998)
- Bourgeois FT, "Adverse drug events in the outpatient setting:an 11-year national analysis", Pharmacoepidemiol Drug Saf, 19(9), pp.901~910 (2010)
- Pirmohamed M, "Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820patients", BMJ, 329(7456), pp.15~19 (2004)
- Jha AK, "Identifying hospital admissions due to adverse drug events using a computer-based monitor", Pharmacoepidemiol Drug Saf, 10(2), pp.113~119 (2001)
- Ernst FR, "Drug-related morbidity and mortality : updating the cost-of-illness model", J Am Pharm Assoc, 41(2), pp.192~199 (2001)
- Cho JH, "A nationwide study of the incidence rate of herb-induced liver injury in Korea", Archives of Toxicology, 91(12), pp.4009~4015 (2017)
- Jeong TY, "A prospective study of the safety of herbal medicines, used alone or with conventional medicines", Journal of Ethnopharmacology, 143, pp.884~888 (2012)
- 이기범, "한방의료기관이용환자의 부작용 및 독성발생의 특성 - 2011년 한방의료이용실태조사(보건복지부)를 중심으로 -", 대한한의학회지, 37(1), pp.135~150 (2016), 대한한의학회
- "의약품의 품목허가‧신고·심사 규정. 식품의약품안전처 고시 제2019-26호"[URL]